Dydrogesterone versus GnRH antagonist for women with low ovarian response using double ovarian stimulation
Official title: Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation: A Randomized Controlled Non-inferiority Trial
Run by Bedaya Hospital · NCT06212102 · Data updated 2026-11-12
This trial will test whether dydrogesterone or a GnRH antagonist better prevents a premature LH surge and improves outcomes and costs for women with poor ovarian response undergoing double ovarian stimulation for IVF.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 35 Years to 44 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Bedaya Hospital Academic / other |
| Locations | 2 sites (Cairo, Cairo Governorate and 1 other locations) |
| Status | Recruiting |
| Started | May 8, 2024 |
| Main results expected | March 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT06212102 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women with infertility classified as POSEIDON group 4 who are planning double ovarian stimulation as part of IVF and who do not have PCOS, endometriosis, or a history of recurrent miscarriage.
✕Probably not a fit
Women with PCOS, endometriosis, recurrent abortion, or those not classified as POSEIDON group 4 or not undergoing double stimulation are unlikely to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase II randomized trial assigns women in POSEIDON group 4 to either progestin-primed ovarian stimulation with dydrogesterone or a standard GnRH antagonist protocol during double ovarian stimulation. The primary focus is prevention of premature LH surge, with secondary outcomes including ovarian response, embryo yield, and cost-effectiveness. Key exclusions are PCOS, endometriosis, and a history of recurrent abortion. The trial is conducted at Cairo University and Bedaya Hospital in the Cairo/Giza region.
Why it matters
Potential benefit: If successful, this could provide a simpler and potentially lower-cost method to prevent premature LH surge and increase usable embryos for women who respond poorly to stimulation.
How similar studies have gone: Progestin-primed ovarian stimulation and GnRH antagonist protocols have each been used successfully in other IVF settings, but randomized head-to-head data specifically in POSEIDON group 4 patients undergoing double stimulation are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients belonging to Poseidon group 4 Exclusion Criteria: * PCOS * Endometriosis * History of recurrent abortion
Where it's running
-
Cairo University
Cairo, Cairo Governorate, Egypt Recruiting -
Bedaya Hospital
Giza, Egypt Not yet recruiting
Study contacts
- Principal investigator: Samar A Alhofy, M.D, Msc — Cairo University
- Study coordinator: Usama M Fouda, Prof.
- Email: umfrfouda@yahoo.com
- Phone: +201095401375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted embryo selection on day 5 in IVF for infertility
This trial tests whether an AI-based embryo selection tool can help pick the best embryo for transfer on day 5 in IVF/ICSI to improve pregnancy chances for people with infertility.
-
Preserving sperm quality with aging through cryopreservation
This study tests whether freezing and thawing sperm can help keep younger-like DNA and molecular traits in men as they age.
-
Unstimulated Egg Retrieval with CAPA-IVM and Euploid Embryo Transfer
This study tests whether eggs can be collected without ovarian stimulation, matured in the lab, and used to create a single euploid embryo for transfer in infertility patients.
-
Ultra-Long GnRH-a Pretreatment Before Frozen Embryo Transfer for Deep Infiltrating Endometriosis
In people under 40 with deep infiltrating endometriosis and infertility, the study tests whether two injections of a GnRH agonist before hormone support improve pregnancy outcomes in their first frozen-thawed embryo transfer.
-
Endometrial Waves and Pregnancy in FET Cycles with Hormone Therapy
This study tests whether patterns of uterine contractions during hormone-prepared frozen embryo transfer affect pregnancy outcomes.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.